In our study, CD74 was shown to be a marker for the infiltration of M1 macrophages in pan-cancer by bulk, spatial, single-cell transcriptional analyses along with immunofluorescence, suggesting that CD74 has potent clinical translational capabilities and may be used in combination with ICIs to reverse “cold” tumors. The gene discussed is CD74; the disease is cancer.